Proteolytic activity of human non-Hodgkin's lymphomas

American Journal of Pathology

Volumn 152, Issue 2, 1998, Pages 565-576

  Kossakowska, Anna E ^a,c   Hinek, Aleksander ^b   Edwards, Dylan R ^a   Lim, Megan S ^a   Zhang, Chun Li ^a   Breitman, Deanne R ^a   Prusinkiewicz, Christopher ^a   Stabbler, Andrea L ^a   Urbanski, Lawrence S ^a   Urbanski, Stefan J ^a  

^a UNIVERSITY OF CALGARY   (Canada)

^b HOSPITAL FOR SICK CHILDREN   (Canada)

^c FOOTHILLS HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ELASTIN; GELATINASE A; GELATINASE B; MATRIGEL; MATRIX METALLOPROTEINASE INHIBITOR; METALLOPROTEINASE;

ARTICLE; EXTRACELLULAR MATRIX; HUMAN; HUMAN CELL; HUMAN TISSUE; LYMPHOID CELL LINE; LYMPHOID HYPERPLASIA; NONHODGKIN LYMPHOMA; PRIORITY JOURNAL; PROTEIN DEGRADATION;

CELL LINE; COLLAGEN; COLLAGENASES; DRUG COMBINATIONS; ELASTIN; ENZYME INHIBITORS; EXTRACELLULAR MATRIX; HUMANS; HYPERPLASIA; LAMININ; LYMPHOID TISSUE; LYMPHOMA, NON-HODGKIN; MATRIX METALLOPROTEINASE 9; METALLOENDOPEPTIDASES; NEOPLASM INVASIVENESS; PEPTIDE HYDROLASES; PROTEOGLYCANS;

EID: 0031905961     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (44)

1. Alexander CM, Werb Z: Extracellular matrix degradation. Cell Biology of Extracellular Matrix. Edited by Hay ED. New York, Plenum Press, 1991, pp 255-302
2. Stetler-Stevenson WG: Dynamics of matrix turnover during pathological remodeling of the extracellular matrix. Am J Pathol 1996, 148: 1345-1350
3. Pauli BU, Knudson W: Tumor invasion: a consequence of destructive and compositional matrix alterations. Hum Pathol 1988, 19:628-639
4. Kohn E, Liotta L: Molecular insights into cancer invasion: strategies for prevention and intervention. Cancer Res 1995, 55:1856-1862
5. Stauder R, Hamader S, Fasching B, Kemmler G, Thaler J, Huber H: Adhesion to high endothelial venules: a model for dissemination mechanisms in non-Hodgkin's lymphoma. Blood 1993, 82:262-267
6. Cottier H, Turk J, Sobin L: A proposal for a standardized system of reporting human lymph node morphology in relation to immunological function. Bull WHO 1972, 47:375-417
7. Duijvestijn A, Hamann A: Mechanisms and regulation of lymphocyte migration. Immunol Today 1989, 10:23-28
8. Müller-Hermelink HK, Lennert K: Lymphocytes Are Destined to Migrate Malignant Lymphomas Other Than Hodgkin's Disease. Edited by Lennert K, Mohn N, Stein H, Kaiserling E, Müller-Hermelink HK. New York, Springer-Verlag, 1978, pp 6-9
9. Cotran RS, Kumar V, Robbins SL: Malignant lymphomas. Robbins Pathologic Basis of Disease. Edited by Cotran RS, Kumar V, Robbins SL. Toronto, WB Saunders, 1989, pp 708-717
10. Matrisian LM: The matrix-degrading metalloproteinases. BioEssays 1992, 14:455-463
11. Mignatti P, Rifkin DB: Biology and biochemistry of proteinases in tumor invasion. Physiol Rev 1993, 73:161-195
12. Ray J, Stetler-Stevenson W: The role of matrix metalloproteases and their inhibitors in tumour invasion, metastasis and angiogenesis. Eur Respir J 1994, 7:2062-2072
13. Woessner JF Jr: Matrix metalloproteinases and their inhibitors in connective tissue remodeling. FASEB J 1991, 5:2145-2154
14. Stetler-Stevenson WG, Hewitt R, Corcoran M: Matrix metalloproteinases and tumor invasion: from correlation and causality to the clinic. Cancer Biol 1996, 7:147-154
15. Kossakowska AE, Urbanski SJ, Huchcroft SA, Edwards DR: Relationship between the clinical aggressiveness of large cell immunoblastic lymphomas and expression of 92 kd gelatinase (type IV collagenase) and tissue inhibitor of metalloproteinase-1 (TIMP-1) RNAs. Oncol Res 1992, 4:233-240
16. Leppert D, Waubant E, Galardy R, Bunnett NW, Hauser SL: T cell gelatinases mediate basement membrane transmigration in vitro. J Immunol 1995, 154:4379-4389
17. Albini A, Iwamoto Y, Kleinman HK, Martin GR, Aaronson SA, Kozlowski JM, McEwam RN: A rapid in vitro assay for quantitating the invasive potential of tumor cells. Cancer Res 1987, 47:3239-3245
18. Kleinman HK, McGarvey ML, Hassell JR, Star VL, Cannon FB, Laurie GW, Martin GR: Basement membrane complexes with biological activity. Biochemistry 1986, 25:312-318
19. Mecham RP, Heuser JE: The elastic fiber. Cell Biology of Extracellular Matrix. Edited by Hay ED. New York, Plenum Press, 1991, pp 79-109
20. Senior RM, Griffin GL, Fliszar CJ, Shapiro SD, Goldgerg GI, Welgus HG: Human 92-and 72-kilodalton type IV collagenases are elastases. J Biol Chem 1991, 266:7870-7875
21. Katsuda S, Okada Y, Okada Y, Imai K, Nakanishi I: Matrix metalloproteinase-9 (92-kd gelatinase/type IV collagenase equals gelatinase B) can degrade arterial elastin. Am J Pathol 1994, 145:1208-1218
22. Wilhelm SM, Collier IE, Marmer BL, Eisen AZ, Grant GA, Goldberg GI: SV40-transformed human lung fibroblasts secrete a 92-kd type IV collagenase which is identical to that secreted by normal human macrophages. J Biol Chem 1989, 264:17213-17221
23. Sato H, Kida Y, Mai M, Endo Y, Sasaki T, Tanaka S, Seiki M: Expression of genes encoding type IV collagen-degrading metalloproteinases and tissue inhibitors of metalloproteinases in various human tumor cells. Oncogene 1992, 7:77-83
24. Mainardi CL, Pourmotabbed TF, Hasty KA: Inflammatory phagocytes and connective tissue degrading metalloproteinases. Am J Med Sci 1991, 302:171-175
25. Ståhl-Bäckdahl M, Sudenbeck BD, Eisen AZ, Welgus HG, Parks WCJ: Expression of 92 kd type IV collagenase by eosinophils associated with basal cell carcinoma. J Invest Dermatol 1992, 99:497-503
26. Stetler-Stevenson M, Mansoor A, Lim M, Fukushima P, Kehrl J, Marti G, Ptaszynski K, Wang J, Stetler-Stevenson WG: Expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases in reactive and neoplastic lymphoid cells. Blood 1997, 89:1708-1715
27. Watanabe H, Nakanishi I, Yamashita K, Hayakawa T, Okada Y: Matrix metalloproteinase-9 (92 kd gelatinase/type IV collagenase) from U937 monoblastoid cells: correlation with cellular invasion. Cell Sci 1993, 104:991-999
28. Zhou H, Bernhard EJ, Fox FE, Billings PC: Induction of metalloproteinase activity in human T-lymphocytes. Biochem Biophys Acta 1993, 11:174-178
29. Kossakowska AE, Urbanski SJ, Watson A, Hayden LJ, Edwards DR: Patterns of expression of metalloproteinases and their inhibitors in human malignant lymphomas. Oncol Res 1993, 5:19-28
30. Sambrook J, Fritsch EF, Maniatis T: Molecular Cloning: A Laboratory Manual, ed 2. Cold Spring Harbor, NY, Cold Spring Harbor Laboratory Press, 1989
31. Wong H, Anderson WD, Cheng T, Riabowol KT: Monitoring mRNA expression by polymerase chain reaction: the "primer-dropping" method. Anal Biochem 1994, 223:251-258
32. Hinek A, Rabinovitch M: The ductus arteriosus migratory smooth muscle cell phenotype processes tropoelastin to a 52-kd product associated with impaired assembly of elastic laminae. J Biol Chem 1993, 268:1405-1413
33. Prosser IW, Whitehouse LA, Parks WC, Ståhle-Bäckdahl M, Hinek A, Park PW, Mecham RP: Polyclonal antibodies to tropoelastin and the specific detection and measurement of tropoelastin in vitro. Connect Tissue Res 1991, 25:265-279
34. Leake DS, Hornebeck W, Brecheimier D, Robert L, Peters TJ: Properties and subcellular localization of elastase-like activities of arterial smooth muscle cells in culture. Biochem Biophys Acta 1983, 761: 41-47
35. Banda MJ, Werb Z: Mouse macrophage elastase. Purification and characterization as metalloproteinase. Biochem J 1981, 193:589-605
36. Belaaouaj A, Shipley JM, Kobayashi DK, Zimonjic DB, Popescu N, Silverman GA, Shapiro SD: Human macrophage metalloelastase: genomic organization, chromosomal location, gene linkage, and tissue-specific expression. J Biol Chem 1995, 270:14568-14575
37. Goetzl EJ, Banda MJ, Leppert D: Matrix metalloproteinases in immunity. J Immunol 1996, 156:1-4
38. Khan KMF, Falcone DJ: Role of laminin in matrix induction of macrophage urokinase-type plasminogen activator and 92-kd metalloproteinase expression. J Biol Chem 1997, 272:8270-8275
39. Kossakowska AE, Urbanski SJ, Edwards DR: Tissue inhibitor of metalloproteinases-1 (TIMP-1) RNA is expressed at elevated levels in malignant non-Hodgkin's lymphomas. Blood 1991, 77:2475-2481
40. Stetler-Stevenson WG, Krutzsch HC, Liotta LA: TIMP-2: identification and characterization of a new member of the metalloproteinase inhibitor family. Matrix Suppl 1992, 1:299-306
41. Leco KJ, Khokha R, Pavloff N, Hawkes SP, Edwards DR: Tissue inhibitor of metalloproteinases-3 (TIMP-3) is an extracellular matrix-associated protein with a distinctive pattern of expression in mouse cells and tissues. J Biol Chem 1994, 269:9352-9360
42. Kolkenbrock H, Hecker-Kia A, Orgel D, Kinawi A, Ulbrich N: Progelatinase B forms from human neutrophils: complex formation of monomer/lipocalin with TIMP-1. Biol Chem 1996, 377:529-533
43. Urbanski SJ, Edwards DR, Gelfand GAJ, Hinek A, Lim M, Kossakowska AE: Proteinases in pulmonary neoplasia. Lab Invest 1995, 72:155A
44. Urbanski SJ, Hinek A, Lim M, Kossakowska AE: Expression of gelatinases A and B mRNA does not correlate with their enzymatic activity in human sporadic colorectal neoplasia. Lab Invest 1995, 72:70A